The quality system shall set out responsibilities, processes and quality risk management principles in relation to the activities of the persons referred to in Article 1(2). All wholesale distribution activities shall be clearly defined and systematically reviewed. All critical steps of wholesale distribution activities and significant changes shall be justified and, where relevant, subject to validation.
The quality system shall encompass the organisational structure, procedures, processes and resources, as well as activities necessary to ensure that the veterinary medicinal products delivered maintain their quality and integrity and remain within the legal supply chain during storage or transport.
The quality system shall be fully documented. Its effectiveness shall be monitored. All quality-system-related activities shall be defined and documented.
A quality manual or equivalent documentation approach shall be established and include a description of any differences in the quality system regarding handling of veterinary medicinal products of different types.
A change control system shall be established and incorporate the principles of quality risk management and be proportionate and effective.
The quality system shall ensure that the following obligations are fulfilled:
the procuring, holding, supplying, transport or export of veterinary medicinal products comply with the requirements of good distribution practice for veterinary medicinal products laid down in this Regulation;
management responsibilities are clearly specified;
veterinary medicinal products are delivered to the correct consignees within an appropriate time period;
records are made contemporaneously;
deviations are documented and investigated;
appropriate corrective and preventive actions (‘CAPA’) are taken in line with the principles of quality risk management;
changes that may affect the storage and distribution of veterinary medicinal products are evaluated.